Bronchoscopies are an invasive procedure used to diagnose problems within a patient’s lungs and airways and are most often performed in a negative pressure room to prevent the spread of fugitive aerosols emitted from the patient. However, exceptions can be made for situations where the patient cannot be moved to such a specialized environment. SafER […]
Many non-hospital healthcare providers such as clinics, urgent care facilities, and mobile health organizations are taking a closer look at how SafER’s low-cost, portable respiratory isolation systems are creating lucrative new revenue opportunities. Providing nebulized medication treatments can potentially provide new revenue streams, however, until recently, these services could only be handled in negative pressure […]
The highly infectious measles virus is one of the most contagious or all diseases, which spreads through airborne particles when the infected person breathes, coughs, or sneezes. These particles can remain infectious in the air for up to two hours after an infected person leaves an area. Following decades of high vaccination rates with the […]
Hospital Administrators, Architects, and Medical System Planners are turning to SafER’s portable systems as an alternative to negative pressure rooms that are expensive to build and operate. Negative pressure rooms require stringent protocols for sanitization, pressurization and depressurization between patients. This time-consuming process takes up time and staff resources that are often needed elsewhere throughout […]
Sputum induction is a non-invasive procedure used to collect sputum (mucus from the lungs) for diagnostic purposes. It is used to diagnose, assess and monitor conditions such as tuberculosis, pneumonia, lung cancer, and other respiratory conditions. However, medical facilities face several challenges with conducting sputum induction safely and cost-effectively. The current standard calls for performing […]
Rural hospitals are an important part of the medical community that can benefit in multiple ways from the implementation and use of SafER’s portable negative pressure system (PNPS) solutions. Often operating with limited resources compared to their larger hospital counterparts, smaller hospitals have less available ‘real estate,’ leading to shared spaces and crowded waiting rooms. […]
Tuberculosis (TB) is the world’s leading cause of death by a single infectious agent. According to the World Health Organization (WHO), 10.8 million people were infected with active TB in 2023, and 1.25 million of those infected lost their lives. In addition, Third World countries often lack the resources we are used to in the […]
The World Health Organization cites a staggering half of the world’s population lacks access to healthcare due to extreme poverty, financial distress prevents their ability to pay for services. Critical issues facing developing countries include the impact of long covid, air pollution resulting from wildfires caused by climate change, and lower respiratory infections like tuberculosis, […]
SafER Medical Products Inc, is pleased to announce a new private placement funding opportunity for accredited investors. As detailed in the Private Placement Memorandum (PPM), this offering will raise a total of $10 million, with the proceeds targeted to fuel SafER’s next stage of rapid growth. The offering is only open to Accredited Investors as […]
SafER Medical, LLC will showcase our innovative Respiratory Shield and Endoshield, portable isolation systems at the AARC Congress American Association for Respiratory Care show November 20 – 23, in Orlando, FL.